Skip to main content
. Author manuscript; available in PMC: 2013 Nov 3.
Published in final edited form as: J Cardiovasc Pharmacol. 2011 Apr;57(4):10.1097/FJC.0b013e31820d92fd. doi: 10.1097/FJC.0b013e31820d92fd

Figure 6.

Figure 6

Expression of Bcl-2 (A) and Bax (B) in aortas of apo E-KO mice injected subcutaneously with EPO (30 U every other day) or an equivalent volume of vehicle (saline) for 10 weeks. (C) Ratio of Bax/Bcl-2 proteins in aortas of apo E-KO mice.(D) Hematocrits of apo E-KO mice following 10 weeks of treatment with saline or EPO. The data displayed represent mean ± s.e. of a total of 10 mice run in triplicate. Asterisk* represents a statistically significant difference (p < 0.05) between the two groups.